PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1982 May; 75(5): 336–340.
PMCID: PMC1437777

Use of the muscle relaxant atracurium in anephric patients: preliminary communication1

Abstract

Atracurium is a new, non-depolarizing muscle relaxant which rapidly breaks down in vivo and appears to require neither renal nor hepatic function for its elimination. As the commonly used non-depolarizing muscle relaxants carry the risk of prolonged effect when used in anephric patients, atracurium appears to have special promise in this situation. A preliminary account of the successful use of the relaxant in 20 anephric patients is recorded and evidence presented that atracurium is, indeed, a suitable agent for use in patients with renal failure.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (576K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Abrams RE, Hornbein TF. Inability to reverse pancuronium blockade in a patient with renal failure and hepatic disease. Anesthesiology. 1975 Mar;42(3):362–364. [PubMed]
  • Ali HH, Savarese JJ. Monitoring of neuromuscular function. Anesthesiology. 1976 Aug;45(2):216–249. [PubMed]
  • Ali HH, Utting JE, Gray C. Stimulus frequency in the detection of neuromuscular block in humans. Br J Anaesth. 1970 Nov;42(11):967–978. [PubMed]
  • Ali HH, Wilson RS, Savarese JJ, Kitz RJ. The effect of tubocurarine on indirectly elicited train-of-four muscle response and respiratory measurements in humans. Br J Anaesth. 1975 May;47(5):570–574. [PubMed]
  • Buzello W, Agoston S. Kinetics of intercompartmental disposition and excretion of tubocurarine, gallamine, alcuronium and pancuronium in patients with normal and impaired renal function. Anaesthesist. 1978 Jul;27(7):319–321. [PubMed]
  • Fahey MR, Morris RB, Miller RD, Nguyen TL, Upton RA. Pharmacokinetics of Org NC45 (norcuron) in patients with and without renal failure. Br J Anaesth. 1981 Oct;53(10):1049–1053. [PubMed]
  • FELDMAN SA, LEVI JA. PROLONGED PARESIS FOLLOWING GALLAMINE; A CASE REPORT. Br J Anaesth. 1963 Dec;35:804–806. [PubMed]
  • Hughes R, Chapple DJ. The pharmacology of atracurium: a new competitive neuromuscular blocking agent. Br J Anaesth. 1981 Jan;53(1):31–44. [PubMed]
  • Payne JP, Hughes R. Evaluation of atracurium in anaesthetized man. Br J Anaesth. 1981 Jan;53(1):45–54. [PubMed]
  • Riordan DD, Gilbertson AA. Prolonged curarization in a patient with renal failure. Case report. Br J Anaesth. 1971 May;43(5):506–508. [PubMed]
  • Rouse JM, Galley RL, Bevan DR. Prolonged curarisation following renal transplantation. A retrospective study. Anaesthesia. 1977 Mar;32(3):247–251. [PubMed]
  • Stovner J, Lund I. The muscle relaxants and their antagonists. Br J Anaesth. 1970 Mar;42(3):235–248. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press